Apollo Genetics, located in Baton Rouge, Louisiana, performs next-generation sequencing (NGS) diagnostics for cancer and pharmacogenetics. The CLIA-certified, CAP-accredited lab performs this testing for reference labs, physicians and directly to individuals. In 2019, Apollo acquired MedCompGx, also a Louisiana-based provider of NGS testing for cancer and pharmacogenetics. Today, the combined organization continues to deliver high-quality technology-driven services.
Next-generation sequencing is complex and requires data-intensive analysis. Learn how Apollo Genetics is leveraging software from Sunquest – Sunquest Mitogen LIMS and Sunquest Mitogen Genetics – across the newly combined organization to scale for volume and complexity, while maximizing efficiency and quality for the patients and physicians they serve.
Download the transcript of this eCase study video.
